Thursday was another important day for psychedelics on Capitol Hill Senators Cory Booker (D-NJ) and Rand Paul (R-KY) jointly filed a bill requesting the DEA move psychedelic “breakthrough therapies” like psilocybin and MDMA from Schedule I to Schedule II, reported  Marijuana Moment. 

This happened shortly after Congress announced the creation of a Congressional Psychedelics Advancing Clinical Treatments (PACT) Caucus. The two measures are closely aligned, as the Senate bill demands removing research barriers for controlled substances, which includes psychedelics, while the caucus was created to promote the advancement of new treatments derived from these substances.

Booker and Paul's legislation proposes …

Full story available on Benzinga.com